Wexford Capital adds Nephros (NEPH) shares in cashless option move
Rhea-AI Filing Summary
NEPHROS INC (NEPH) had insider activity reported by entities associated with Wexford Capital LP. On 2026-08-18, Wexford Capital exercised stock options to purchase 3,765 shares of common stock at an exercise price of $3.60 per share through a cashless exercise, with a portion of the option shares withheld to satisfy the exercise price. This resulted in the acquisition of 812 shares of common stock, bringing Wexford Capital’s direct common stock holdings to 56,872 shares and leaving 36,198 stock options outstanding, expiring on August 24, 2026. Wexford GP LLC, Charles E. Davidson and Joseph M. Jacobs may be deemed controlling persons of Wexford Capital and disclaim beneficial ownership except to the extent of any pecuniary interests. The transactions were not reported as made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 812 shares
Net Buy
2 txns
Insider
WEXFORD CAPITAL LP, Wexford GP LLC, DAVIDSON CHARLES E, JACOBS JOSEPH
Role
10% Owner | 10% Owner | 10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F3, F4 | 3,765 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 812 | $3.60 | $3K |
Holdings After Transaction:
Stock Option (Right to Buy) — 36,198 shares (Direct);
Common Stock — 56,872 shares (Direct)
Footnotes (4)
- F1. Represents the net number of shares of common stock issued upon the cashless exercise of stock options to purchase 3,765 shares, after a portion of the option shares was withheld to satisfy the exercise price.
- F2. Includes shares of common stock granted to Wexford Capital LP ("Wexford Capital") as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital.
- F3. One-third of the options vested immediately upon the grant date of August 24, 2016. The remainder of the options vested in equal annual installments on each of the first and second anniversaries of the grant date.
- F4. Includes stock options granted to Wexford Capital as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital.
Key Figures
Options Exercised: 3,765 stock options
Exercise Price: $3.60 per share
Net Shares Issued: 812 shares
+4 more
7 metrics
Options Exercised
3,765 stock options
Stock options to buy NEPH common stock exercised on 2026-08-18
Exercise Price
$3.60 per share
Exercise price of stock options on NEPH common stock
Net Shares Issued
812 shares
Common shares issued from cashless option exercise on 2026-08-18
Common Shares Held After Transaction
56,872 shares
Wexford Capital LP direct NEPH common stock holdings post-transaction
Options Held After Transaction
36,198 stock options
Remaining NEPH stock options held by Wexford Capital LP
Option Expiration Date
August 24, 2026
Expiration date of the remaining stock options
Transaction Date
August 18, 2026
Date of the cashless option exercise and related share issuance
Key Terms
cashless exercise, beneficially owned, pecuniary interests, ten percent owner
4 terms
cashless exercise financial
"Represents the net number of shares of common stock issued upon the cashless exercise"
A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.
beneficially owned financial
"the securities beneficially owned by Wexford Capital"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
pecuniary interests financial
"except to the extent of any pecuniary interests therein"
ten percent owner regulatory
"reporting persons are marked as a ten percent owner"
FAQ
What insider transaction did NEPH (NEPHROS INC) report in this Form 4?
Entities associated with Wexford Capital LP reported a cashless exercise of stock options for 3,765 shares of NEPHROS INC common stock on 2026-08-18, resulting in the net issuance of 812 shares of common stock and a reduction in option holdings.
Was the NEPH Form 4 transaction by Wexford Capital done under a Rule 10b5-1 plan?
No. The Form 4 for NEPHROS INC indicates the Rule 10b5-1 checkbox is not affirmed, meaning the reported transactions were not designated as being made under a Rule 10b5-1 trading plan.
Who are the reporting persons on the NEPH Form 4 besides Wexford Capital LP?
The reporting persons are Wexford Capital LP, Wexford GP LLC, Charles E. Davidson, and Joseph M. Jacobs. Wexford GP, Davidson, and Jacobs may be deemed controlling persons of Wexford Capital and disclaim beneficial ownership except for any pecuniary interests.
What is the exercise price of the NEPH stock options involved in this Form 4?
The stock options exercised in the NEPHROS INC transaction have an exercise price of $3.60 per share. The exercise was conducted on a cashless basis, with a portion of the option shares withheld to satisfy the exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
